TriSalus Life Sciences, Inc. (TLSI) Stock Analysis

Company Overview

TriSalus Life Sciences, Inc. (TLSI) carries a market capitalisation of $307.87M. The company sits in the Healthcare sector, in the Medical Devices industry. Headcount on file is 102.

Over the past 52 weeks the price has ranged from $2.20 to $7.95. The most recent close on file for TLSI is $5.00, dated September 4, 2026. That is +$0.02 (+0.40%) against the previous close. The latest close sits 127.27% above that 52-week low.

Financial Health

The most recent full year on file, fiscal 2025, shows revenue of $45.15M. That is +53.41% against the prior fiscal year, when revenue was $29.43M. The same year closed with a net loss of $39.23M. The reported profit margin is −62.59%. That is 60.9 percentage points below the Medical Devices median of −1.69%. Trailing earnings per share are −1.33.

Across the 4 fiscal years on file, revenue moves from $12.40M in 2022 to $45.15M in 2025. Of those 4 years, 0 report positive net income.

Valuation Assessment

The record shows negative trailing earnings, so no price-to-earnings ratio is published. The price-to-sales ratio is 6.83. On price-to-sales that is 129.49% above the Medical Devices median of 2.98. 151 Medical Devices companies report these metrics, and the medians quoted come from that group.

The reported beta is 0.44. Annualized volatility over the trailing 5 years is 61.2%. The trailing one-year price return is −2.91%. Across 5 years the annualized return works out at −12.75%.

Growth & Income

No dividend is on file for TLSI.

So far in 2026 the price is −28.37%. The strongest complete calendar year on file is 2025 at +39.32%; the weakest is 2024 at −40.71%. Of the 4 complete calendar years on file, 2 finished higher.